Viewing Study NCT06081361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-01-29 @ 9:01 AM
Study NCT ID: NCT06081361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-01
First Post: 2023-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
Sponsor: Beijing Chest Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Tuberculosis View
None Rifampicin-resistant Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tuberculosis View
None Rifampicin-resistant View
None short regimen View
None contezolid View
None delamanid View